Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 471 participants.

Also called NCT03011450

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 471 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03011450
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belarus, Bulgaria, Czechia, Georgia, Hungary, Poland, Russia, Ukraine (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03011450. Randomized; triple masking; primary purpose treatment. Start 2016-11-26 (actual); primary completion 2019-07-05 (actual). Results posted on 2022-10-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
Condition
Severe Hypertriglyceridemia
Intervention (Drug)
K-877
Intervention (Drug)
Fenofibrate
Intervention (Drug)
Placebo (for K-877)
Lead sponsor
Kowa Research Institute, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03011450
Content hash
1698b330b90f81bdd3418560e3330827790a98da749e0e66cfa5ecd97fcaff76